Affordable Access

Access to the full text

Frequent SLC35A2 brain mosaicism in mild malformation of cortical development with oligodendroglial hyperplasia in epilepsy (MOGHE)

  • Bonduelle, Thomas1
  • Hartlieb, Till2, 3
  • Baldassari, Sara1
  • Sim, Nam Suk4
  • Kim, Se Hoon5
  • Kang, Hoon-Chul5
  • Kobow, Katja6
  • Coras, Roland6
  • Chipaux, Mathilde7
  • Dorfmüller, Georg7
  • Adle-Biassette, Homa8
  • Aronica, Eleonora9, 10
  • Lee, Jeong Ho4, 11
  • Blumcke, Ingmar6
  • Baulac, Stéphanie1
  • 1 Sorbonne Université, Hôpital Pitié-Salpêtrière - 47, bd de l’hôpital, Paris, 75013, France , Paris (France)
  • 2 Schoen Klinik, Vogtareuth, Germany , Vogtareuth (Germany)
  • 3 Paracelsus Medical University, Salzburg, Austria , Salzburg (Austria)
  • 4 KAIST, Daejeon, Korea , Daejeon (South Korea)
  • 5 Yonsei University College of Medicine, Seoul, Korea , Seoul (South Korea)
  • 6 Universitätsklinikum Erlangen, Friedrich-Alexander University (FAU) Erlangen-Nürnberg, Erlangen, Germany , Erlangen (Germany)
  • 7 Rothschild Foundation Hospital, Paris, 75019, France , Paris (France)
  • 8 AP-HP, Hôpital Lariboisière, DMU DREAM, UMR 1141, INSERM, Paris, France , Paris (France)
  • 9 Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands , Amsterdam (Netherlands)
  • 10 Stichting Epilepsie Instellingen Nederland (SEIN), Heemstede, The Netherlands , Heemstede (Netherlands)
  • 11 SoVarGen, Inc., Daejeon, 34051, Republic of Korea , Daejeon (South Korea)
Published Article
Acta Neuropathologica Communications
Springer (Biomed Central Ltd.)
Publication Date
Jan 06, 2021
DOI: 10.1186/s40478-020-01085-3
Springer Nature


Focal malformations of cortical development (MCD) are linked to somatic brain mutations occurring during neurodevelopment. Mild malformation of cortical development with oligodendroglial hyperplasia in epilepsy (MOGHE) is a newly recognized clinico-pathological entity associated with pediatric drug-resistant focal epilepsy, and amenable to neurosurgical treatment. MOGHE is histopathologically characterized by clusters of increased oligodendroglial cell densities, patchy zones of hypomyelination, and heterotopic neurons in the white matter. The molecular etiology of MOGHE remained unknown so far. We hypothesized a contribution of mosaic brain variants and performed deep targeted gene sequencing on 20 surgical MOGHE brain samples from a single-center cohort of pediatric patients. We identified somatic pathogenic SLC35A2 variants in 9/20 (45%) patients with mosaic rates ranging from 7 to 52%. SLC35A2 encodes a UDP-galactose transporter, previously implicated in other malformations of cortical development (MCD) and a rare type of congenital disorder of glycosylation. To further clarify the histological features of SLC35A2-brain tissues, we then collected 17 samples with pathogenic SLC35A2 variants from a multicenter cohort of MCD cases. Histopathological reassessment including anti-Olig2 staining confirmed a MOGHE diagnosis in all cases. Analysis by droplet digital PCR of pools of microdissected cells from one MOGHE tissue revealed a variant enrichment in clustered oligodendroglial cells and heterotopic neurons. Through an international consortium, we assembled an unprecedented series of 26 SLC35A2-MOGHE cases providing evidence that mosaic SLC35A2 variants, likely occurred in a neuroglial progenitor cell during brain development, are a genetic marker for MOGHE.

Report this publication


Seen <100 times